SCHEMBL10289767

SCHEMBL10289767

N=C1CCCc2ccccc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 1/20 0.56
▸ MAOA P21397 1/20 0.56
▸ MAOB P27338 1/20 0.56
▸ TSHR P16473 1/20 0.48
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ HPGD P15428 1/20 0.45
▸ CES1 P23141 1/20 0.44
▸ NOS3 P29474 2/20 0.44
▸ DRD4 P21917 1/20 0.43
▸ NOTUM Q6P988 1/20 0.42
▸ CYP19A1 P11511 5/20 0.42
▸ CYP11B1 P15538 5/20 0.42
▸ CYP11B2 P19099 5/20 0.42
▸ MAPT P10636 1/20 0.42
▸ MIF P14174 1/20 0.42
▸ G6PC1 P35575 1/20 0.40
▸ NPY5R Q15761 1/20 0.39
▸ BCHE P06276 2/20 0.38
▸ NOS2 P35228 1/20 0.38
▸ ACHE P22303 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6753858 0.85 CES1 (0.54) CYP2A6MAOAMAOBTSHRL3MBTL1
SCHEMBL3103992 0.82 CYP2A6 (0.68) CYP2A6MAOAMAOBTSHRL3MBTL1
SCHEMBL30505637 0.82 CYP2A6 (0.68) CYP2A6MAOAMAOBTSHRL3MBTL1
SCHEMBL30436320 0.79 CYP2A6 (0.65) CYP2A6MAOAMAOBTSHRL3MBTL1
SCHEMBL9652088 0.79 CYP2A6 (0.65) CYP2A6MAOAMAOBTSHRL3MBTL1
SCHEMBL31430380 0.76 TSHR (0.71) CYP2A6MAOAMAOBTSHRL3MBTL1
SCHEMBL568779 0.76 TSHR (0.71) CYP2A6MAOAMAOBTSHRL3MBTL1
SCHEMBL7102942 0.74 MEN1 (0.36) CYP2A6MAOAMAOBTSHRL3MBTL1
SCHEMBL31135519 0.74 TSHR (0.67) CYP2A6MAOAMAOBTSHRL3MBTL1
SCHEMBL31621255 0.74 TSHR (0.67) CYP2A6MAOAMAOBTSHRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-213049951-U Tetrahydroimine dust recovery device 河南源博新材料有限公司 2021-04-27 — — CN claimed
CN-116655582-B Synthesis method and application of sanguinarine intermediate compound bromo-compound 宁波九胜创新医药科技有限公司 2026-05-12 — — CN disclosed
CN-116444478-B Preparation method and application of aromatic benzo [ c ] phenanthridine alkaloid intermediate compound 宁波九胜创新医药科技有限公司 2024-12-06 — — CN disclosed
CN-116655582-A Synthesis method and application of sanguinarine intermediate compound bromo-compound 宁波九胜创新医药科技有限公司 2023-08-29 — — CN disclosed
CN-116444478-A Preparation method and application of aromatic benzo [ c ] phenanthridine alkaloid intermediate compound 宁波九胜创新医药科技有限公司 2023-07-18 — — CN disclosed
CN-109879792-B Polysubstituted isoindole compound and preparation method thereof 广东工业大学 2022-06-24 — — CN disclosed
EP-3705477-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS Vertex Pharmaceuticals Incorporated (US) 2020-09-09 — — EP disclosed
US-10662192-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2020-05-26 — — US disclosed
EP-3216787-B1 INTERMEDIATES FOR THE PREPARATION OF MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMA (US) 2020-02-19 — — EP disclosed
EP-3561876-A1 DISPLAY Novaled GmbH (DE) 2019-10-30 — — EP disclosed
US-20090298876-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-12-03 — — US disclosed
EP-2116527-A1 OXIME COMPOUND, PHOTOSENSITIVE COMPOSITION, COLOR FILTER, METHOD FOR PRODUCTION OF THE COLOR FILTER, AND LIQUID CRYSTAL DISPLAY ELEMENT FUJIFILM Corporation (JP) 2009-11-11 — — EP disclosed
US-20090246820-A1 COMPOUNDS USEFUL IN CFTR ASSAYS AND METHODS THEREWITH VERTEX PHARMACEUTICALS INCORPORATED 2009-10-01 — — US disclosed
US-20090227797-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-09-10 — — US disclosed
US-7495103-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-02-24 — — US disclosed
US-20080071095-A1 Cystic fibrosis transmembrane conductance VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-03-20 — — US disclosed
US-4088786-A Method for utilizing tetrahydro-4-imino-1-naphthylureas as growth promoting agents for animals AMERICAN CYANAMID COMPANY (US) 1978-05-09 — — US disclosed
US-4076952-A ANIMAL GROWTH PROMOTERS AMERICAN CYANAMID COMPANY (US) 1978-02-28 — — US disclosed
US-4072711-A ANIMAL GROWTH REGULATORS AMERICAN CYANAMID COMPANY (US) 1978-02-07 — — US disclosed
US-4041070-A ANIMAL GROWTH PROMOTERS, ENHANCING FEED EFFICIENCY AMERICAN CYANAMID COMPANY (US) 1977-08-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227797-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS CFTR, ABCB1, ABCC2 CYP2A6 1793/4885MAOA 3867/4885MAOB 2865/4885
US-10662192-B2 Modulators of ATP-binding cassette transporters CFTR, ABCB1, ABCC2 CYP2A6 1793/4885MAOA 3867/4885MAOB 2865/4885
US-20090298876-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS CFTR, ABCB1, ABCC2 CYP2A6 1793/4885MAOA 3867/4885MAOB 2865/4885
US-20080071095-A1 Cystic fibrosis transmembrane conductance CFTR, ABCB1, ABCC1 CYP2A6 3185/4885MAOA 4364/4885MAOB 3796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback